🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Mild Alzheimer's Disease

Longitudinal Profiling of Plasma-Derived Glial Extracellular Vesicles in Alzheimer's Disease NCT07803055NA1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: blood sampling Reducing African American's Alzheimer's Risk Through Exercise-Mild Cognitive Impairment (RAATE-MCI) NCT04956549NA1 site📍 Baton Rouge Pennington Biomedical Research Center · Tests: Physical activity program, Successful Aging Closed-Loop Brain Stimulation as a Potential Intervention for Cognitive Decline NCT05907343NA1 site📍 Austin University of Texas at Austin · Tests: Closed-loop TBS, Open-loop TBS Digital Solutions for Predicting the Biological Mechanisms of Alzheimer's Disease Through the Analysis of Risk Factors NCT07731191NA2 sites📍 Brescia📍 Brescia IRCCS Centro San Giovanni di Dio Fatebenefratelli · Tests: Digital solution for the prediction of the biological mechanisms of Alzheimer's disease through the analysis of ri… Neurocognitive Assessment Platform 4 Alzheimer NCT07272811n/a1 site📍 Milan IRCCS San Raffaele Positive Psychology for Early Cognitive Decline: Effects on Cognitive and Brain Function NCT07289061NA1 site📍 Thessaloniki Aristotle University Of Thessaloniki · Tests: Positive Psychology Intervention, Treatment as usual (TAU) Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging NCT07202494n/a1 site📍 Marseille Assistance Publique Hopitaux De Marseille · Tests: Imaging Techniques (MRI 3T & 7T, Functional, Structural, and Metabolic Imaging) Crownlands Observing Progression With Neurons Study NCT07611396n/a1 site📍 Germantown Crownlands PUMCH Dementia Longitudinal Cohort Study NCT05023564n/a1 site📍 Beijing Peking Union Medical College Hospital Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease NCT05924425Phase 41 site📍 Montpellier University Hospital, Montpellier · Tests: Daridorexant 50 mg, Placebo, Polysomnography, Neuropsychological assessment, Questionnaires on sleep and behavioural pr… Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD) NCT06362707Phase 26 sites📍 Tromsø📍 Oslo📍 Haugesund Helse Stavanger HF · Tests: Fasudil, Placebo Clinical Cohort of Memory Disorders NCT07880275n/a1 site📍 Seoul Yonsei University Study to Understand Novel Biomarkers in Researching Dementia NCT06547099n/a1 site📍 St Louis Washington University School of Medicine · Tests: Clinical tau PET, Clinical amyloid test, Research blood collection, Cognitive assessments Exploratory Study of Low-Dose Whole-Brain Radiation Therapy With HeLaXON 1X in Patients With Mild Alzheimer's Disease Dementia NCT07863011NA1 site📍 Cheonan ReadyCure Inc. · Tests: HeLaXON 1X Low-Dose Radiation Therapy, Sham HeLaXON 1X Procedure Cardiac Amyloid Deposits and Heart Dysfunction in Alzheimer's Disease NCT07154394n/a1 site📍 Essen University Hospital, Essen An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease NCT05908695Phase 450 sites📍 Huainan📍 Beijing📍 Beijing Green Valley (Shanghai) Pharmaceuticals Co., Ltd. · Tests: GV-971, Placebo Retinal Imaging in Neurodegenerative Disease NCT03233646n/a1 site📍 Durham Duke University · Tests: Retinal and Choroidal Imaging ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults NCT07392723Phase 21 site📍 New Brunswick Michal Schnaider Beeri, Ph.D. · Tests: Alpha-Linolenic Acid (2.6 g/day), Placebo Control Group Repurposing Siponimod for Alzheimer's Disease NCT06639282Phase 21 site📍 Phoenix St. Joseph's Hospital and Medical Center, Phoenix · Tests: Siponimod, Placebo Shanghai Non-pharmacological Intervention for Mild Cognitive Impairment and Mild Alzheimer's Disease NCT05887674NA1 site📍 Shanghai Ruijin Hospital · Tests: Diet intervention, Exercise, Cognitive training A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE) NCT07633470Phase 422 sites📍 Irvine📍 Orange📍 Aventura Alpha Cognition, Inc · Tests: Zunveyl® A Study of Retinal Imaging to Detect Abnormal Protein Deposits Associated With Alzheimer's Disease NCT07254234n/a3 sites📍 Abu Dhabi📍 Abu Dhabi📍 Abu Dhabi Eli Lilly and Company · Tests: Retinal scan, Blood test Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease NCT05295615NA1 site📍 Hackensack Herrick Medical LLC · Tests: ECHS AD Device Understanding Brain Mechanisms Involved in Autobiographical Memory NCT05710549NA1 site📍 Geneva Lucie Bréchet · Tests: high-density electroencephalography (hdEEG), Transcranial alternating current stimulation (tACS) An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symptomatic Alzheimer's Disease NCT07724132Phase 32 sites📍 Cambridge📍 Chertsey University College, London · Tests: Placebo, Atomoxetine, Metformin 1000 mg Oral Tablet The Effect of Urolithin A (Mitopure®) on Alzheimer's Disease NCT07842146NA1 site📍 Prague University Hospital, Akershus · Tests: Urolithin A, Placebo Control Pulsed Electromagnetic Field Treatment With Dementia Patients NCT06862557NA1 site📍 Boca Raton Herrick Medical LLC · Tests: ECHS AD Device Global Collaborative Research on Establishing a Korean Cognitive Aging Cohort NCT07485387n/a1 site📍 Seoul Korea University Evaluate the Concordance Between PET Imaging of [18F]-APN-1607 Injection and Postmortem Brain Tissue Tau Pathology in Individuals With HV and MCI or AD. NCT07752784Phase 31 site📍 Beijing JYAMS PET Research & Development Limited · Tests: [18F]-APN-1607 Predicting Pre-dementia NCT07516119n/a1 site📍 San Diego Prevention Research Consortium Corp.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy